Molecules (Basel, Switzerland), 2017-08, Vol.22 (8), p.1329
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Significance of Resveratrol in Clinical Management of Chronic Diseases
- Ist Teil von
- Molecules (Basel, Switzerland), 2017-08, Vol.22 (8), p.1329
- Ort / Verlag
- Switzerland: MDPI AG
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Resveratrol could be beneficial to health and provides protection against a wide array of pathologies and age-associated problems, as evident from preclinical studies. However, a comparison of animal and human studies reveals that this dietary polyphenol cannot protect against metabolic diseases and their associated complications. The clinical outcomes are affected by many factors such as sample size. This article not only presents a comprehensive review of the current advances concerning the dose, the extent of absorption, interaction and toxicity of resveratrol in human studies, but also describes its therapeutic effects against several chronic diseases such as diabetes mellitus, obesity, cardiovascular diseases, cancer and aging and the related diseases.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1420-3049eISSN: 1420-3049DOI: 10.3390/molecules22081329Titel-ID: cdi_doaj_primary_oai_doaj_org_article_2b1e5d8a70c5469b845add9c9d54cad9
- Format
- –
- Schlagworte
- absorption, Aging, Aging - drug effects, Aging - pathology, Cancer, Cardiovascular diseases, Cardiovascular Diseases - drug therapy, Cardiovascular Diseases - pathology, Chronic Disease - drug therapy, Chronic illnesses, clinical studies, Complications, Diabetes mellitus, Diabetes Mellitus - drug therapy, Diabetes Mellitus - pathology, Dose-Response Relationship, Drug, Humans, Metabolic disorders, Neoplasms - drug therapy, Neoplasms - pathology, obesity, Obesity - drug therapy, Obesity - pathology, Polyphenols - therapeutic use, pre-clinical studies, Resveratrol, Review, Stilbenes - therapeutic use, Toxicity